Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2020-09-30 Option Award |
2020-10-06 3:20 pm |
N/A 2025-09-30 |
RespireRx Pharmaceuticals Inc. | RSPI | Dickason David SVP of Pre-Clinical Prod. Dev. |
2,000,000 | $0 | 2,000,000 (Direct) |
View |
| 2020-09-30 Other |
2020-10-02 3:51 pm |
2020-09-30 2023-09-30 |
RespireRx Pharmaceuticals Inc. | RSPI | Jones Timothy L. CEO and President |
28 | $0 | 8,818,154 (Direct) |
View |
| 2020-09-30 Conversion |
2020-10-02 3:51 pm |
2020-09-30 2023-09-30 |
RespireRx Pharmaceuticals Inc. | RSPI | Jones Timothy L. CEO and President |
4,409,091 | $0 | 8,818,154 (Direct) |
View |
| 2020-09-30 Option Award |
2020-10-02 3:50 pm |
N/A 2025-09-30 |
RespireRx Pharmaceuticals Inc. | RSPI | MacFarlane Katie Director |
5,000,000 | $0 | 5,000,000 (Direct) |
View |
| 2020-09-30 Other |
2020-10-02 3:47 pm |
2020-09-30 2023-09-30 |
RespireRx Pharmaceuticals Inc. | RSPI | Lippa Arnold Exec. Chairman & CSO |
100 | $0 | 100 (Direct) |
View |
| 2020-09-30 Gift |
2020-10-02 3:47 pm |
2020-09-30 2023-09-30 |
RespireRx Pharmaceuticals Inc. | RSPI | Lippa Arnold Exec. Chairman & CSO |
200 | $0 | 100 (Direct) |
View |
| 2020-09-30 Other |
2020-10-02 3:47 pm |
2020-09-30 2023-09-30 |
RespireRx Pharmaceuticals Inc. | RSPI | Margolis Jeff Eliot SVP, CFO, Secret'y & Treasurer 10% Owner |
150 | $0 | 107,048,556 (Direct) |
View |
| 2020-09-30 Conversion |
2020-10-02 3:47 pm |
2020-09-30 2023-09-30 |
RespireRx Pharmaceuticals Inc. | RSPI | Margolis Jeff Eliot SVP, CFO, Secret'y & Treasurer 10% Owner |
101,905,382 | $0 | 107,048,556 (Indirect) |
View |
| 2020-09-30 Gift |
2020-10-02 3:47 pm |
2020-09-30 2023-09-30 |
RespireRx Pharmaceuticals Inc. | RSPI | Margolis Jeff Eliot SVP, CFO, Secret'y & Treasurer 10% Owner |
300 | $0 | 107,048,556 (Direct) |
View |
| 2020-07-31 Option Award |
2020-08-04 2:28 pm |
N/A 2025-07-31 |
RespireRx Pharmaceuticals Inc. | RSPI | MacFarlane Katie Director |
7,500,000 | $0 | 7,500,000 (Direct) |
View |
| 2020-07-31 Option Award |
2020-08-04 2:25 pm |
N/A 2025-07-31 |
RespireRx Pharmaceuticals Inc. | RSPI | Purcell Richard David Jr. SVP - Research and Development |
5,000,000 | $0 | 5,000,000 (Direct) |
View |
| 2020-07-31 Option Award |
2020-08-04 2:21 pm |
N/A 2025-07-31 |
RespireRx Pharmaceuticals Inc. | RSPI | Jones Timothy L. CEO and President |
17,000,000 | $0 | 17,000,000 (Direct) |
View |
| 2020-07-13 Other |
2020-07-15 9:14 pm |
2020-07-13 2023-09-30 |
RespireRx Pharmaceuticals Inc. | RSPI | Lippa Arnold Exec. Chairman, CEO & CSO |
600 | $0 | 600 (Direct) |
View |
| 2020-07-13 Gift |
2020-07-15 9:14 pm |
2020-07-13 2023-09-30 |
RespireRx Pharmaceuticals Inc. | RSPI | Lippa Arnold Exec. Chairman, CEO & CSO |
1,200 | $0 | 600 (Direct) |
View |
| 2020-07-13 Other |
2020-07-15 6:13 pm |
2020-07-13 2023-09-30 |
RespireRx Pharmaceuticals Inc. | RSPI | Margolis Jeff Eliot SVP, CFO, Secret'y & Treasurer 10% Owner |
500 | $0 | 1,075 (Direct) |
View |
| 2020-07-13 Gift |
2020-07-15 6:13 pm |
2020-07-13 2023-09-30 |
RespireRx Pharmaceuticals Inc. | RSPI | Margolis Jeff Eliot SVP, CFO, Secret'y & Treasurer 10% Owner |
1,000 | $0 | 1,075 (Direct) |
View |